JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M001706200 on April 26, 2000

J. Biol. Chem., Vol. 275, Issue 32, 24798-24806, August 11, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/32/24798    most recent
M001706200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Board, P. G.
Right arrow Articles by Pandit, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Board, P. G.
Right arrow Articles by Pandit, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Identification, Characterization, and Crystal Structure of the Omega Class Glutathione Transferases*

Philip G. BoardDagger §, Marjorie CogganDagger , Gareth Chelvanayagam||, Simon Easteal, Lars S. Jermiin**, Gayle K. SchulteDagger Dagger , Dennis E. DanleyDagger Dagger , Lise R. HothDagger Dagger , Matthew C. GrifforDagger Dagger , Ajith V. KamathDagger Dagger , Michele H. RosnerDagger Dagger , Boris A. ChrunykDagger Dagger , David E. PerregauxDagger Dagger , Christopher A. GabelDagger Dagger , Kieran F. GeogheganDagger Dagger , and Jayvardhan Pandit§Dagger Dagger

From the Dagger  Molecular Genetics Group and  Human Genetics Group, John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory 2601, Australia, ** Australian Genomic Information Centre, University of Sydney, New South Wales 2006, Australia, and Dagger Dagger  Pfizer Global Research and Development, Groton, Connecticut 06340

Received for publication, March 2, 2000, and in revised form, April 10, 2000

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

A new class of glutathione transferases has been discovered by analysis of the expressed sequence tag data base and sequence alignment. Glutathione S-transferases (GSTs) of the new class, named Omega, exist in several mammalian species and Caenorhabditis elegans. In humans, GSTO 1-1 is expressed in most tissues and exhibits glutathione-dependent thiol transferase and dehydroascorbate reductase activities characteristic of the glutaredoxins. The structure of GSTO 1-1 has been determined at 2.0-Å resolution and has a characteristic GST fold (Protein Data Bank entry code 1eem). The Omega class GSTs exhibit an unusual N-terminal extension that abuts the C terminus to form a novel structural unit. Unlike other mammalian GSTs, GSTO 1-1 appears to have an active site cysteine that can form a disulfide bond with glutathione.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The glutathione transferases (GSTs)1 are a family of phase II enzymes that utilize glutathione in reactions contributing to the biotransformation and disposition of a wide range of exogenous and endogenous compounds. These include chemical carcinogens, therapeutic drugs, and products of oxidative stress (1). GST expression levels and the factors modulating them can have significant biological and clinical implications. Overexpression of some GSTs is implicated in resistance to several anti-cancer drugs (1). In contrast, genetically determined GST deficiencies are risk factors for cataract and several forms of cancer (1, 2), and homozygosity for the GSTM 1 null allele is a positive prognostic indicator for successful chemotherapy and long term survival in childhood acute lymphoblastic leukemia (3). Genetic polymorphisms influencing the substrate specificity of GSTP 1-1 (4) are risk factors for Parkinson's disease in subjects exposed to pesticides (5)

Based on their sequences, the mammalian cytosolic GSTs form six evolutionarily distinct classes termed Alpha, Mu, Pi, Sigma, Theta, and Zeta (1, 6). There may also be additional classes in plants, insects, and other species (6). Although some members of the different GST classes exhibit overlapping substrate specificities, others are highly specific. Despite the diversity of substrates metabolized by this large family, many GSTs were originally identified through their activity with the xenobiotic 1-chloro-2,4-dinitrobenzene and their ability to bind to glutathione affinity matrices. To identify new members of the glutathione transferase gene family on the basis of sequence similarity rather than substrate specificity, we have searched a data base containing sequences of more than 106 human expressed sequence tags.

This analysis has led to identification of the class Omega glutathione transferases, a group of GSTs with novel structural and functional characteristics. We have identified a human cDNA, expressed and characterized the recombinant protein, and determined its crystal structure to 2.0-Å resolution. Recombinant human Omega class GST (GSTO 1-1) exhibits a glutathione-dependent thiol transferase activity and catalyzes glutathione-dependent reduction of dehydroascorbate. These activities are not associated with other human GSTs but are characteristic of the glutaredoxins (7). The Omega class GSTs have a unique N-terminal extension, and the crystal structure reveals an active site cysteine residue distinct from the tyrosine and serine residues characteristic of other eukaryotic GSTs (8-10).

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

EST Identification and DNA Sequencing-- The human EST data base was searched using the tBLASTn version of the BLAST program (11) with human Theta and Zeta class amino acid sequences as query sequences. An EST (GenBankTM accession number W38456) encoding an unknown protein with low similarity to both Theta and Zeta class GSTs was identified, and the cDNA clone was obtained from the I.M.A.G.E. consortium. The complete cDNA sequence was obtained on each strand by subcloning restriction fragments and by the use of a Thermo sequenase kit (Amersham Pharmacia Biotech). The cDNA sequence has been submitted to GenBankTM as accession number AF212303.

Alignment and Phylogenetic Analysis of Representative GST and GST-like Amino Acid Sequences-- Although a large number of GSTs and related protein sequences are available, to simplify computations and to promote legibility, representative GST and GST-like amino acid sequences were selected from previously described GST classes and related proteins. The sequences were obtained from GenBankTM and aligned using CLUSTAL W (12) and GDE (13). The revised alignment, which agrees with predictions based on molecular modeling and crystal structure, is available from Dr. P. Board at the John Curtin School of Medical Research web site.

A phylogenetic tree was obtained by maximum likelihood analysis of all the sites in the above-mentioned alignment. The data was analyzed using the JTT-F substitution model (14), and local bootstrap probabilities were estimated for the internal branches using the PROTML program (15).

The phylogenetic analysis involved two examinations of the sequence alignment with different input order of the sequences. Each analysis involved two steps: stepwise addition and nearest neighbor interchanges. The most likely tree was compared with the remaining trees using the test of Kishino and Hasegawa (16).

Recombinant Protein Expression-- Recombinant GSTO 1-1 was expressed in Escherichia coli and purified by two separate methods using either the pGEX2T vector (Amersham Pharmacia Biotech, Piscataway, NJ) and glutathione affinity chromatography or the pQE30 vector (Qiagen) and nickel agarose affinity chromatography. Specifically, the GSTO1 cDNA was amplified by polymerase chain reaction (sense primer 5'-AGGATCCACGATGTCCGGGGAGTCAG-3', antisense primer 5'-CGAATTCAGAGCCCATAGTCACAG-3') and cloned between the BamHI and EcoRI sites of the bacterial expression vector pGEX2T (Amersham Pharmacia Biotech), and transformed into BL21 [DE3] cells (Novagen, Milwaukee, WI). Briefly, a seed culture of the transformed cells was grown to A600 of 0.4-0.6, scaled up, and grown again to the same density, induced with IPTG (50 µM), and grown for a further 2 h at 37 °C. The GST fusion protein product was purified from the soluble fraction of a cell lysate and cleaved with thrombin. GSTO 1-1 was isolated by further chromatography using anion exchange.2

Recombinant GSTO 1-1 was also expressed with an N-terminal 6×His tag from the plasmid pQE30 and purified on nickel agarose largely as described for the preparation of recombinant mouse GSTT 1-1 (17). The enzyme was eluted in 500 mM imidazole, 50 mM sodium phosphate, 300 mM NaCl, pH 8.0, and was essentially pure as judged by SDS-PAGE. The purified protein was dialyzed against 20 mM Tris-Cl, 60 mM NaCl, 5 mM dithiothreitol, pH 8.0, before storage at -80 °C.

Expression and Purification of Selenomethionine (SeMet)-substituted GSTO 1-1-- For crystallography by the multiwavelength anomalous dispersion method, GSTO 1-1 was expressed as a SeMet-substituted protein. pGEX-2T with the GSTO 1-1 insert was transformed into the methionine auxotroph E. coli B834 (Novagen), and the resulting cells were grown in the presence of 100 mg/liter D,L-selenomethionine (Bachem) essentially as described previously (18).2

Crystal Growth-- Purified GSTO 1-1 was exchanged into fresh 0.025 M Tris-HCl, 0.06 M NaCl, 5 mM dithiothreitol, pH 7.5, and brought to 20-25 mg/ml in Centricon units (Millipore, Bedford, MA). When the intent was to crystallize the covalent glutathione adduct of GSTO 1-1, dithiothreitol was used at 1 mM, and GSH:GSSG (5:1) was added to 2 mM. Screening by hanging drop/vapor diffusion using Crystal Screen I (Hampton Research, Laguna Hills, CA) identified a condition (#47) requiring minimal optimization. Both glutathione-complexed and glutathione-free crystals grew in drops containing 8-12 mg/ml protein with 50 mM sodium acetate, pH 4.6, and 1.0-1.2 M (NH4)2SO4.

Quaternary Structure of GSTO 1-1-- Size exclusion chromatography was conducted on a Amersham Pharmacia Biotech fast protein liquid chromatography system using a Superdex 75 HR 10/30 column equilibrated with phosphate-buffered saline and run at a flow rate of 0.8 ml/min. Standards (Sigma) included bovine serum albumin (66 kDa), bovine carbonic anhydrase (29 kDa), horse cytochrome c (12.4 kDa), and bovine aprotinin (6.5 kDa).

Sedimentation equilibrium studies were performed using a Beckman XLA analytical ultracentrifuge. Sample concentrations of 0.11, 0.17, and 0.34 mg/ml in charcoal epon cells were centrifuged at rotor speeds of 18,000, 25,000, and 31,000. Samples were referenced to the dialysis buffer (phosphate-buffered saline, 5 mM dithiothreitol). Data were analyzed using the program NONLIN (University of Connecticut, Storrs, CT).

Enzyme Assays-- Enzymatic activity with a range of substrates (Table I) was determined as described (6, 17, 19). Thiol transferase activity was measured with hydroxyethyl disulfide as a substrate (20), and glutathione-dependent dehydroascorbate reductase activity was determined spectrophotometrically with dehydroascorbate prepared immediately before use (21). For the thiol transferase and dehydroascorbate reductase assays, the purified enzyme was dialyzed against 20 mM Tris-HCl, 60 mM NaCl, pH 8.0, to remove dithiothreitol.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Activity of recombinant GST0 1-1 with various substrates
All values are the mean ± S.D. of between 3 and 6 determinations. ND, not detectable.

Northern and Western Blotting-- Northern blots containing mRNA from multiple human tissues obtained from CLONTECH (Palo Alto, CA) were hybridized with 32P-labeled GSTO 1-1 cDNA in ExpressHyb (CLONTECH, Palo Alto, CA) at 68 °C and washed according to the manufacturer's instructions. The filters were subsequently hybridized with a labeled beta -actin cDNA probe to evaluate track loading. Western blots were developed with a 1:400 dilution of rabbit antiserum raised against His-tagged recombinant GSTO 1-1, and goat anti-rabbit IgG alkaline phosphatase conjugate (Sigma) (22). The primary antiserum does not cross-react with native GSTs from the other classes; however, we have noted some cross-reactivity with recombinant proteins expressed with the poly-His tag.

Data Collection-- Multiwavelength anomalous dispersion data were collected from crystals of SeMet-substituted apo-GSTO 1-1 on Beam Line X12-C of the National Synchrotron Light Source at the Brookhaven National Laboratory, Brookhaven, New York. Before data collection at 100 K, crystals were transferred to a cryoprotectant solution of 2.0 M Li2SO4 and 5% glycerol. The Se-absorption edge was determined by a fluorescence scan, and three wavelengths were selected for data collection corresponding to the peak (maximum f ', lambda  = 0.9795 Å), the inflection point (minimum f ', lambda  = 0.9802 Å), and a high energy wavelength remote from the edge (lambda  = 0.9500 Å). Inverse beam geometry was employed, and data were collected in two 75° sweeps in 0.5° oscillation steps for each wavelength, using a Brandeis charge-coupled device detector. All data were indexed, measured, and scaled with the DENZO and SCALEPACK programs (23) and then processed with the CCP4 package (24). Data on native (i.e. not SeMet-substituted) crystals with and without glutathione covalently bound were collected on a Rigaku Raxis II image plate detector using copper-Kalpha x-rays from a Rigaku RU-200 generator equipped with Molecular Structure Corp. focusing mirrors. Relevant statistics are given in Table II.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Structure determination statistics

Structure Determination-- Four of the seven expected selenium sites were found in anomalous difference Patterson maps calculated at the peak anomalous wavelength using the program PATSOL (25), and initial phases were calculated with SHARP (26). Examination of log-likelihood gradient maps revealed two more selenium sites. The last remaining selenium site corresponding to methionine near the N terminus (the fourth amino acid residue of the recombinant protein) was disordered and was not placed. Phase calculation in SHARP using the six located sites gave phases with an excellent overall figure of merit (Table II). 2.1 Å resolution maps calculated after density modification by histogram matching and solvent flipping in SOLOMON (27) were used for model building (Fig. 1).


View larger version (60K):
[in this window]
[in a new window]
 
Fig. 1.   Stereo view of a part of the experimental electron density map after solvent flipping, contoured at 2.0sigma . The region shown is part of the N-terminal extension, residues Gly12-Pro18

Model Building and Refinement-- The initial model was built using the program O (28). The high quality of the initial experimental electron density map and known selenium sites allowed unambiguous tracing for all of the protein backbone and side chains except for the first seven amino acids. The first three (Gly-Ser-Thr) were a legacy of the recombinant construct. The protein model was refined against 2.0-Å data collected from native (non SeMet) crystals of the GSTO 1-1 complex with GSH. Refinement was carried out using conjugate-gradient least squares and simulated-annealing protocols in X-PLOR 3.851 (29) and monitored with the Rfree value using a 5% randomly selected test set. A model for GSH covalently bound to Cys-32 as well as chemically reasonable water molecules and sulfate ions was built into sigma A-weighted 2 Fo - Fc maps (30). The final model contained 110 water molecules, 2 sulfate ions, disulfide-linked GSH, and the entire polypeptide minus the first seven residues. Final model statistics are shown in Table III.

                              
View this table:
[in this window]
[in a new window]
 
Table III
Refinement statistics


    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

DNA and Protein Sequence-- BLAST searches of the human EST data base with residues 1-100 of human GSTZ1 (6) revealed clones with around 40% sequence identity with the residues between positions 19 and 77 of GSTZ1. Preliminary alignments suggested these were distinct from previously described human GSTs, and a representative EST clone (GenBankTM accession number W38456) was selected for further characterization. Subsequent studies revealed that this cDNA encoded a protein belonging to a distinct new class within the GST family. This class has been named Omega in accordance with established guidelines (31).

Sequencing of both strands of the cDNA contained in the EST clone W38456, which we termed pGSTO 1, revealed 26 base pairs of 5' non-coding sequence, 723 base pairs of coding sequence, and 51 base pairs of 3' non-coding sequence (Fig. 2). The cDNA encodes a peptide of 241 residues with a predicted molecular mass of 27,566 Da. A similar cDNA sequence encoding the same peptide has been submitted to GenBankTM by others with accession number U90313. Alignment of the deduced amino acid sequence with representative sequences from previously described GST classes and GST-like proteins2 highlights the similarities and significant differences between GSTO 1-1 and the previously defined classes. Although we first identified GSTO 1-1 as a human EST, searches of additional data bases have identified highly similar sequences in the mouse (U80819), rat (AB008807), and a nematode (Caenorhabditis elegans) (P34345). These have 72, 76, and 34% sequence identity respectively. A pig EST (F14520) also shows sufficient similarity over its incomplete sequence to be placed in the Omega class.


View larger version (46K):
[in this window]
[in a new window]
 
Fig. 2.   Nucleotide and deduced amino acid sequences of GSTO 1. The poly(A) addition signal is underlined.

The sequence alignment was used to generate a phylogenetic tree using the maximum-likelihood approach. The tree in Fig. 3 is the most likely tree; another five locally optimal trees were identified, none differing significantly from the most likely tree. The tree in Fig. 3 clearly groups human Omega with the homologous sequences from the mouse, rat, and nematode in a distinct cluster, supporting the designation of this group as the Omega class. The alignment and tree also show that the Zeta class is the most similar of the previously defined classes and that the well characterized GST classes are all supported by local bootstrap probabilities ranging from 90 to 100%. Several sequences not yet clearly characterized as GSTs (i.e. soybean heat-shock protein, yeast membrane protein, and E. coli stringent starvation protein) were included in the alignment because they appear to be members of the GST structural family. The phylogenetic relationships of these sequences are uncertain, but there is an indication that the potato GST and soybean heat-shock protein are part of the Omega class.


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 3.   An unrooted phylogeny showing the most likely relationship between representative GST and GST-like amino acid sequences. Branch lengths are proportional to estimates of evolutionary change. The number associated with each internal branch is the local bootstrap probability that is an indicator of confidence. Another five locally optimal trees were found, none of which differ significantly from the most likely tree. The differences between the six trees were confined to the branches, indicated by dashed lines. The sequences are (species name; GenBankTM accession number): nematode Omega (C. elegans; L23651), mouse Omega (Mus musculus; U80819), rat Omega (Rattus rattus; AB008807), human Omega (Homo sapiens; AF212303), soybean heat-shock protein (HsPr) (Glycine max; M20363), potato GST (Solanum tuberosum; J03679), yeast membrane protein (MbPr, Saccharomyces cerevisiae; Z73165), nematode Zeta (C. elegans, Z66560), human Zeta (H. sapiens, NM_001513), carnation Zeta (Dianthus caryophyllus, M64268), Escherichia stringent starvation protein (StStPr) (E. coli, X05088), Proteus GST (Proteus mirabilis, U38482), Escherichia GST (E. coli, D38497), Ochrobactrum GST (Ochrobactrum anthropi, Y17279), Arabidopsis Phi (A. thaliana, D17672), Petunia Phi (Petunia hybrida, Y07721), blowfly Delta (L. cuprina, L23126), house fly Delta (Musca domestica, X61302), fruit fly Delta (Drosophila melanogaster, X14233), mouse Theta (M. musculus, U48419), human Theta (H. sapiens, NM_000854), mouse Mu (M. musculus, J03952), human Mu (H. sapiens, NM_000848), chicken Mu (Gallus gallus, X58248), rat Pi (Rattus norvegicus, L29427), human Pi (H. sapiens, NM_000852), rat Sigma (R. norvegicus, D82071), human Sigma (H. sapiens, D82073), squid2 Sigma (Ommastrephens sloanei, M36938), squid1 Sigma (O. sloanei, M36937), human Alpha (H. sapiens, NM_000846), mouse Alpha (M. musculus, M73483), and chicken Alpha (G. gallus, L15386).

A notable feature of the human, mouse, pig, and nematode Omega GSTs is a 19-20-residue N-terminal extension not found in any previously described GST. This was not noted in the homologous rat sequence reported as a glutathione-dependent dehydroascorbate reductase (32), but translation with a reading frame adjustment of the rat sequence upstream of the reported translation-initiating ATG codon reveals an N-terminal sequence similar to that in the other species. Additional rat cDNAs need to be sequenced to determine if there is a species difference or if there is a cloning artifact in the clone reported by Ishikawa et al. (32).

GSTO 1 Expression-- Northern blots of RNA from a range of human tissues showed a single hybridizing species of approximately 0.8 kilobases (Fig. 4). The level of hybridization indicates that GSTO 1 mRNA is expressed in all tissues tested, with the greatest expression in liver, skeletal muscle, and heart and relatively low levels in brain, placenta, and lung. The level of expression in skeletal muscle and heart is difficult to judge accurately because the loading control hybridization with a beta -actin probe shows strong hybridization to an extra 1.8-kilobase band that tends to obscure the 2-kilobase beta -actin band found in all tissues. A survey of the EST data base has confirmed that GSTO 1 is expressed in a wide range of human tissues including aorta, bone, brain, breast, central nervous system, colon, esophagus, foreskin, germ cell, heart, kidney, lung, lymph, muscle, ovary, pancreas, parathyroid, placenta, prostate, spleen, stomach, testis, uterus, and whole embryo. The broad range of expression of GSTO 1 contrasts with many other GSTs that show distinct tissue-specific expression and suggests that it plays a fundamental role in cellular metabolism.


View larger version (63K):
[in this window]
[in a new window]
 
Fig. 4.   Tissue distribution of GSTO 1-1 mRNA expression. The blotted RNA was initially hybridized with the GSTO 1-1 cDNA, then rehybridized with a beta  actin cDNA to evaluate RNA loading.

Characterization of Recombinant GSTO 1-1-- A Western blot of cytosolic extracts from human liver and Jurkat cells revealed a single cross-reacting protein with an apparent mass of 31 kDa (not shown), co-migrating with purified recombinant GSTO 1. As the deduced amino acid sequence predicts a mass of 27.5 kDa, GSTO 1 migrates anomalously in reducing SDS-PAGE. Size exclusion chromatography of recombinant GSTO 1 on a calibrated Superdex 75 HR 10/30 column estimated its mass as 56 kDa, indicating that GSTO 1 forms a dimer (GSTO 1-1) under native conditions. Sedimentation equilibrium experiments were conducted at protein concentrations of 0.11, 0.17, and 0.34 mg/ml. For the two higher concentrations, NONLIN analysis yielded good fits to molecular masses of 54,545 Da (0.34 mg/ml) and 54,145 Da (0.17 mg/ml), each indicating a dimer. The data collected at 0.11 mg/ml displayed evidence of some non-ideality and fit better to a model taking account of some non-equilibrium behavior (90% dimer and 10% incompetent monomer). More extensive studies would be needed to confirm this observation and extend it into a lower concentration range.

To test recombinant GSTO 1-1 for GST-like activities, assays were performed with compounds that are substrates for GSTs of other classes. Also, as the homologous rat sequence was reported to encode a glutathione-dependent dehydroascorbate reductase (32), that activity and glutathione-dependent thiol transferase activity were determined. GSTO 1-1 has little activity with most GST substrates (Table I). There was low but detectable activity with 1-chloro-2,4-dinitrobenzene, which is generally a good substrate for members of the Alpha, Mu, and Pi classes. Similarly, there was low but measurable activity with 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl) trans-octenal and trans-nonenal, substrates utilized preferentially by Alpha class GSTs (22).

Glutathione-dependent dehydroascorbate reductase activity was detected in preparations of recombinant human GSTO 1-1. This has been reported in a number of tissues from several species (33) and, in most cases, attributed to glutaredoxin (also termed thiol transferase). Consequently, the thiol transferase activity of the recombinant enzyme was determined and found to be the highest of all the activities investigated (Table I) Similar results were obtained with GSTO 1-1 prepared from a GST fusion or with an N-terminal His tag. Thus the Omega class GSTs have activities similar to those of the glutaredoxins.

Similarities in the protein fold of the glutaredoxins and the N-terminal domain of the cytosolic GSTs have been noted (34), and low thiol transferase activity (74.3 nmol/mg/min) has been attributed to a Mu class GST from bovine lens (35). In other unpublished studies we examined the thiol transferase activity of a range of GSTs from the Alpha, Mu, Pi, Theta, and Zeta classes (GSTA 1-1, GST 2-2, GSTA 4-4, GSTM 1-1, GSTM 2-2, GSTM 3-3, GSTM 4-4, GSTP 1-1, GSTT 2-2, GSTT 1-1, GST Z 1-1). With the exception of GSTM2-2, which had low activity, all were essentially inactive. It is therefore clear that the glutaredoxin-like activities of GSTO 1-1 are not a common feature of other cytosolic GSTs despite similarities in their structure.

Crystal Structure of GSTO 1-1-- The structure of a covalent complex between GSTO 1-1 and GSH was determined to 2.0-Å resolution by multiwavelength anomalous dispersion. Multiwavelength anomalous dispersion data to 2.1 Å resolution were collected from crystals of SeMet-substituted apo-GSTO 1-1 (Table II). The crystals are trigonal, belong to space group P3121, and have a single polypeptide in the asymmetric unit. Two monomers related by the crystallographic 2-fold axis form a dimer, as is characteristic of GSTs (Fig. 5A).


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 5.   Structure of human GSTO 1-1. A, the GSTO 1-1 dimer, as seen looking down the 2-fold axis. The N- and C-terminal extensions (see text under "Crystal Structure of GSTO 1-1") are highlighted in red. The GSH molecules and bound sulfate ions are indicated in ball and stick representation. B, a ribbon representation of the monomer. Residues were assigned to secondary structural elements according to criteria defined by Kabsch and Sander (51). The secondary structure nomenclature has been made consistent with other published GST structures. Helices alpha 2 and alpha 10 are 310 helices, and other helices are alpha -helices. These images were generated using the program RIBBONS (52).

GSTO 1-1 has modest sequence identity with the GSTs for which crystal structures are known but clearly adopts the canonical GST fold (Fig. 5B). There are two domains, an N-terminal thioredoxin-like domain, and a C-terminal domain that is all alpha -helical. The N-terminal domain consists of a central four-stranded beta -sheet flanked on one side by two alpha -helices (alpha 1, residues 32-45; alpha 3, residues 85-97) and on the other side by a 310 helix (alpha 2, residues 60-66). The N-terminal extension identified by sequence alignment2 forms a distinct structural unit that other structures lack (Fig. 6). Residues 5-22 form an extended structure on the surface of the protein that leads into the first beta -strand (beta 1, 23-28) (Figs. 5A and 6).


View larger version (62K):
[in this window]
[in a new window]
 
Fig. 6.   The common chain fold of the GST superfamily. The coordinates of all nine structures were superimposed and then pulled apart for clarity. Helices are represented as cylinders, and beta -strands are represented as arrows. Assignment of secondary structure was done according to criteria defined by Kabsch and Sander (51). Protein data bank codes and references for the structures used are: alpha, 1gse (53); beta, 2pmt (36); delta, (40); theta, 1ljr (54); mu,1hna (55); pi, 1glp (56); sigma, 1gsq (57); phi, 1gnw (39); omega, 1eem (this work). Images in this figure were drawn using the programs MOLSCRIPT (58) and RASTER3D (59).

Of the seven alpha -helices in the C-terminal domain, five (alpha 4, alpha 5, alpha 6, alpha 7, alpha 8) are common to most members of the GST folding superfamily (Fig. 6), but the last two (alpha 9, 219-230 and alpha 10, 235-239) fold back over the top of the N-terminal domain and set the present structure apart. This C-terminal extension makes several H-bonds with the N-terminal domain and forms a continuous surface with the N-terminal extension (Fig. 7)


View larger version (100K):
[in this window]
[in a new window]
 
Fig. 7.   Surface representation of the GST-Omega dimer, looking down the 2-fold axis. The N- and C-terminal extensions (see text under "Crystal Structure of GSTO 1-1") are colored green and purple, respectively. GSH molecules are shown in ball and stick representation. This figure was drawn using the program GRASP (60).

G-site and the Recognition of GSH-- Two features of GSH binding distinguish GSTO 1-1 from typical GSTs. The first is that Cys-32 makes a mixed disulfide with GSH, as seen also in the bacterial enzyme PmGST B1-1 (36). As noted in that case, the presence of this disulfide prompts caution in considering possible catalytic functions of GSTO 1-1. It is unclear what catalytic residues would stabilize the thiolate form of glutathione for the standard GST function of transferring it to an electrophile. In the human Mu class enzyme GSTM2-2 it has been suggested that movement of a positvely charged Arg residue into the catalytic pocket promotes the ionization of the sulfhydryl group of GSH (37). However, examination of the GSTO 1-1 structure has not identified any atoms within 5 Å of the Cys-32 thiol that could be involved in stabilizing a thiolate ion.

Cys-32 is located at the N terminus of alpha 1, with its thiol precisely over the helix axis. This placement is exactly as seen for the thiol of the N-terminal cysteine of the Cys-Xaa-Xaa-Cys motif of thioredoxin, glutaredoxin, and DsbA (Fig. 8 shows structural overlap of GSTO 1-1 and glutaredoxin). This structural feature appears likely to have major implications for the function of GSTO 1-1. As shown by Kortemme and Creighton (38), the proximity of the Cys side chain to the positive end of a helix dipole substantially lowers the thiol pKa and creates the potent nucleophilicity of the exposed cysteine in thioredoxin and its relatives. The proline following this cysteine, as Pro-33 follows Cys-32 of GSTO 1-1, promotes optimal positioning of the Cys-32 thiol for stabilization of the thiolate form (38).


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 8.   Comparison of the GSH binding loop in glutaredoxin (left) and GST-Omega (right). The glutaredoxin structure shown is from Protein Data Bank entry 3grx, an NMR structure determination of the C15S mutant of E. coli glutaredoxin complexed with GSH. The figure shows residues 1-23 in glutaredoxin and residues 23-44 in GST-Omega from the superimposed protein structures. Cys-11 from glutaredoxin and Cys-32 from GST-Omega are shown in ball and stick representation.

The second novel feature is the absence of interactions between GSH bound to one polypeptide and groups of the other polypeptide. In the other known GST structures, except for the Theta-like GSTs from plant (Arabidopsis thaliana (39)) and insect (Lucilia cuprina (40)) species, there is a salt bridge between the N-terminal nitrogen of GSH and an acidic residue on helix alpha 4 of the second subunit (Asp-101 in GST-Alpha, Glu-104 in GST-Beta, Asp-105 in GST-Mu, Asp-98 in GST-Pi, Asp-101 in GST-Sigma, and Asp-104 in mammalian GST-Theta). The corresponding residue in GSTO 1-1 is Lys-122. The GSTO 1-1 dimer has an atypically open, V-shaped configuration. Contacts between the subunits are confined to side chains from beta 4, alpha 3, and alpha 4. Most of the interactions at the interface are non-polar in character, with no H-bonds and only two salt bridges (the two instances of Lys-114-Glu-91). The relative orientation of the monomers at the subunit interface is consistent with the orientation seen in the other GST crystal structures (10), but the interface is more open than in any of the other GST dimers. The buried area at the interface is 1960 Å2, compared with 2700-3400 Å2 in most other GST dimers. The plant Theta-like GSTs (39), which also lack an inter-subunit interaction involving GSH, have a relatively open dimer interface with a buried surface area of 2370 Å2.

In all other respects, GSH binding is analogous to what has been observed in other GSTs. All the interactions of GSH with the protein are made with the N-terminal domain, and residues that contribute to binding GSH are either conserved or conservatively replaced in all the GSTs (Fig. 9). Glu-85, which forms a H-bond with the amino group of GSH, has strained backbone stereochemistry and is in the generously allowed region of the Ramachandran plot. The equivalent residue in other GST structures also adopts a strained conformation (10).


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 9.   Schematic illustrating the residues contacting GSH. This figure was generated using the program LIGPLOT (61).

The H-site-- Many GSTs catalyze conjugation of the thiol group of GSH to an electrophile, often a component of a toxic xenobiotic with some hydrophobic character. The canonical GST structure has a binding site known as the H-site, which accommodates a hydrophobic moiety and is adjacent to the glutathione binding G-site. The H-site is constructed from elements of both the N- and C-terminal domains, and variations of these between different GST classes reflect the varying substrate specificities of GSTs.

GSTO 1-1 possesses a well defined cavity adjacent to the GSH binding site in the same relative location as the H-site in other GSTs, and this is presumed to be the binding site for a substrate or other molecular target (Fig. 10). One side of this wide and deep pocket is formed by Phe-31 and Pro-33, which flank the putative catalytic or otherwise reactive Cys-32. Residues from the C-terminal helix alpha 8, a distinctive feature of GSTO 1-1, form the top and back of this pocket. Particularly interesting is Trp-222, with its indole nitrogen pointing into the pocket. The indole nitrogen contributes one additional H-bond to the pocket, making the pocket that much less hydrophobic. Another polar atom is contributed by the side chain of Arg-183, the Nepsilon atom of which forms the bottom of the pocket. The open subunit interface and the relatively polar nature of the H-site suggest that the substrate or other binding partner for GSTO 1-1 could be a large and not entirely hydrophobic molecule. The cleft between the subunits is large enough that binding to another protein appears possible.


View larger version (93K):
[in this window]
[in a new window]
 
Fig. 10.   Putative substrate or target-binding site in GSTO 1-1. A GRASP image shows the deep cleft adjoining the GSH-binding site that corresponds to the H-site in other GST structures. The surface is colored according to electrostatic potential (blue, positive; red, negative; white, neutral). Some of the residues forming the walls of the pocket are indicated (see text under "The H-site").


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Our sequence-based searches of the human EST data base identified what appeared to be a new member of the GST structural family. Independently, a recent study evaluating a new data base searching tool suggested the existence of an additional GST family in the mouse (41). The unknown enzyme was termed GSTX. Sequence comparisons indicate that GSTX is the orthologue of the human GSTO 1-1 characterized in this study. Because the term GSTX does not conveniently lend itself to the established nomenclature (31), we have named the new gene family Omega. Sequence alignment suggested that GST Omega was a new member of the GST structural family, and phylogenetic analysis confirmed that the Omega class GSTs form a cluster distinct from the previously described classes. Further detailed phylogenetic studies are required to gain a greater understanding of the evolutionary history of the GSTs and the clear demarcation of the different classes. Our analysis of the GSTO 1-1 structure has also confirmed its membership of the GST superfamily. GSTO 1-1 is a dimer of subunits that adopt a characteristic GST fold with an N-terminal alpha /beta GSH binding domain and a C-terminal domain composed entirely of alpha  helices.

Several features set GSTO 1-1 apart from the other members of the GST superfamily. Its N-terminal region has a unique extension of approximately 19 residues when compared with other cytosolic GSTs. This contains a proline-rich segment that in conjunction with the C terminus forms a distinct structural unit with an unknown function. An active site Cys is another notable feature of GSTO 1. Previously characterized eukaryotic GSTs have a tyrosine or serine residue within hydrogen-bonding distance of the sulfur atom of the bound glutathione (8, 10). It is generally considered that a H-bond between the GSH sulfur and the OH of the tyrosine or serine stabilizes the thiolate anion of GSH (42). Mutation of the active site tyrosine and serine residues found in other GSTs generally results in a substantial, if not complete, inactivation (8, 9). Consequently the absence of an equivalent residue in the Omega class GSTs suggests that they may not catalyze the glutathione conjugation reactions typical of many GSTs. The Theta class isoenzyme GSTT 2-2 provides an interesting example of a novel reaction that does not require the presence of a H-bond from a nearby hydroxyl to stabilize the GSH thiolate. GSTT 2-2 acts as a sulfatase with menaphthyl sulfate and generates menaphthyl glutathione and free sulfate. Mutagenesis has suggested that this reaction is not dependent on the presence of a serine and may be a product of the environment generated by a number of residues (43, 44). This notable difference demonstrates that some reactions catalyzed by GSTs can take place in the absence of a tyrosine or serine residue, and an equivalent mechanism may be utilized by the Omega class GSTs.

Studies of the enzymatic properties of GSTO 1-1 also indicated that it probably is not a typical GST. Known substrates for other members of the GST superfamily were not turned over by GSTO 1-1. Interestingly, GSTZ 1-1, the human GST with the closest sequence similarity to GSTO 1-1, catalyzes glutathione-dependent conversion of dichloroacetic acid to glyoxylic acid (45), but GSTO 1-1 has no significant activity against dichloroacetic acid. Thus, the enzymatic capabilities of GSTO 1-1 appear distinct from those of other GSTs. The only significant activity observed for GSTO 1-1 was the ability to act as a glutathione-dependent S-thioltransferase. This type of activity is consistent with expectations that Cys-32 serves as a nucleophilic center, based on structural homology to thioredoxin and glutaredoxin and preliminary unpublished studies indicating that the enzymatic activities of GSTO 1-1 are sensitive to alkylation by N-ethylmaleimide. Potential disulfide-containing molecules that may serve as natural substrates for this type of activity include S-thiolated polypeptides. For example, following oxidative stress a number of cellular proteins form S-thiol adducts with glutathione and cysteine (46, 47), and formation of these adducts can inactivate enzymatic functions of the affected polypeptides (48, 49). A conceivable function for GSTO 1-1 is to reduce this type of S-thiol adduct and restore enzymatic function. Interestingly, the crystal structure of GSTO 1-1 indicates that its H site is open to the surface and large enough to accommodate a polypeptide chain.

Mouse and rat orthologues of GSTO 1-1 have been identified and characterized in recent reports. Comparison of the cDNAs prepared from radiation-sensitive and radiation-resistant populations of mouse lymphoma cells identified a 28-kDa polypeptide (p28) as more highly expressed in the resistant cells (50). The p28 protein (GenBankTM number accession U80819) is predicted to be expressed as a 240-residue polypeptide. This is one amino acid shorter than human GSTO 1-1, with the extra residue in the human sequence (Thr-162) occurring in a surface loop. p28 has 72% sequence identity with human GSTO 1-1, with many conservative replacements where the sequences differ.

In apparent contrast to our findings with GSTO 1-1, p28 is reported to bind to agarose-coupled glutathione. However, our studies were conducted using Glutathione-Sepharose (Amersham Pharmacia Biotech), in which glutathione is linked to the support through its sulfydryl. The earlier study was conducted using Glutathione-agarose (Sigma), in which glutathione is immobilized through its N terminus and retains the free thiol. Because Cys-32 of GSTO 1-1 can form a mixed disulfide with glutathione, murine p28 may have bound to glutathione-agarose (Sigma) via formation of a covalent adduct. When p28 was released from the resin by boiling the complex in SDS sample buffer, reducing agent in the disaggregation buffer may have reduced the mixed disulfide and liberated the polypeptide. Thus, differences in the composition of the affinity matrix may explain the apparent differences in glutathione binding by the mouse and human proteins.

Like GSTO 1-1, p28 lacks demonstrable GST activity, and the recombinant mouse protein is devoid of glutathione peroxidase activity (50). Moreover, message encoding GSTO 1-1 and p28 is expressed by many tissues, with liver and heart containing the highest levels. Interestingly, p28 is reported to change its subcellular location in response to heat (50). On this basis p28 may represent a component of the stress response mechanism of the cells.

A rat orthologue of GSTO 1-1 (GenBankTM number accession AB008807) has been purified from rat liver on the basis of its ability to catalyze a glutathione-dependent reduction of dehydroascorbic acid (32). Like its human and mouse orthologues, the rat protein is widely expressed, with rat liver and kidney demonstrating the highest levels.

The recombinant rat protein was not shown directly to catalyze the glutathione-dependent reduction of dehydroascorbic acid. Rather, cells overexpressing the recombinant protein were reported to accumulate more ascorbic acid than non-transfected control cells following exposure to dehydroascorbate, and this was interpreted as evidence of greater dehydroascorbate reductase activity. Human recombinant GSTO 1-1 demonstrated dehydroascorbate reductase activity, but its magnitude was rather low. Pig liver glutaredoxin, for example, possesses a specific activity of 134 units/mg as a glutathione-dependent dehydroascorbate reductase (21), but the specific activity of GSTO 1-1 for this same reaction is 0.16 units/mg (1 unit is equivalent to 1 µmol/min). Therefore, the extent to which GSTO 1-1 serves as a glutathione-dependent dehydroascorbate reductase in vivo remains to be determined.

The wide and relatively abundant expression of GSTO 1-1 in most tissues and the detection of similar sequences in species ranging from C. elegans to humans suggests that it may have a significant housekeeping role. Protection against oxidative stress is an ancient and ongoing problem for living organisms. Given the catalytic proclivities of GSTO 1-1 detected so far and the overexpression of its mouse orthologue in radiation-resistant cells, it is conceivable that it plays a significant role in the cellular response to oxidative stress.

    ACKNOWLEDGEMENTS

We thank Salvatore Sclafani and Robert Sweet for assistance with the data collection and John P. Overington for the program MNYFIT used for calculating all protein structure overlaps. The School of Biological Sciences at the University of Sydney is gratefully acknowledged for providing temporary space and resources to L. S. Jermiin.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF212303.

The atomic coordinates and structure factors (code 1eem) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).

§ To whom correspondence should be addressed. To P. Board: Tel.: 61 2 62494714; Fax: 61 2 62490413; E-mail: Philip.Board@anu.edu.au. To J. Pandit: Tel.: 860-441-3738; Fax: 860-441-4734; E-mail: pandit@ pfizer.com.

|| Recipient of an Australian Research Council post-doctoral fellowship.

Published, JBC Papers in Press, April 26, 2000, DOI 10.1074/jbc.M001706200

2 Further details are available from Dr. Philip Board at the John Curtin School of Medical Research web site.

    ABBREVIATIONS

The abbreviations used are: GST, glutathione S-transferase; EST, expressed sequence tag; PAGE, polyacrylamide gel electrophoresis; SeMet, selenomethionine.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Hayes, J. D., and Pulford, D. J. (1995) Crit. Rev. Biochem. Mol. Biol. 30, 445-600
2. Sekine, Y., Hommura, S., and Harada, S. (1995) Exp. Eye Res. 60, 159-163
3. Hall, A. G., Autzen, P., Cattan, A. R., Malcolm, A. J., Cole, M., Kernahan, J., and Reid, M. M. (1994) Cancer Res. 54, 5251-5254
4. Zimniak, P., Nanduri, B., Pikula, S., Bandorowicz-Pikula, J., Singhal, S. S., Srivastava, S. K., Awasthi, S., and Awasthi, Y. C. (1994) Eur. J. Biochem. 224, 893-899
5. Menegon, A., Board, P. G., Blackburn, A. C., Mellick, G. D., and Le Couteur, D. G. (1998) Lancet 352, 1344-1346
6. Board, P. G., Baker, R. T., Chelvanayagam, G., and Jermiin, L. S. (1997) Biochem. J. 328, 929-935
7. Washburn, M. P., and Wells, W. W. (1999) Biochem. Biophys. Res. Commun. 257, 567-571
8. Board, P. G., Coggan, M., Wilce, M. C., and Parker, M. W. (1995) Biochem. J. 311, 247-250
9. Stenberg, G., Board, P. G., and Mannervik, B. (1991) FEBS Lett. 293, 153-155
10. Wilce, M. C., and Parker, M. W. (1994) Biochim. Biophys Acta 1205, 1-18
11. Altschul, S. F., Madden, T. L., Schaffer, A. A., Zhang, J., Zhang, Z., Miller, W., and Lipman, D. J. (1997) Nucleic Acids Res. 25, 3389-3402
12. Thompson, J. D., Higgins, D. G., and Gibson, T. J. (1994) Nucleic Acids Res. 22, 4673-4680
13. Smith, S. W., Overbeek, R., Woese, C. R., Gilbert, W., and Gillevet, P. M. (1994) Comput. Appl. Biosci. 10, 671-675
14. Jones, D. T., Taylor, W. R., and Thornton, J. M. (1992) Comput. Appl. Biosci. 8, 275-282
15. Adachi, J., and Hasegawa, M. (1996) MOLPHY Version 2.3 , The Institute of Mathematical Statistics, Tokyo
16. Kishino, H., and Hasegawa, M. (1989) J. Mol. Evol. 29, 170-179
17. Whittington, A., Vichai, V., Webb, G., Baker, R., Pearson, W., and Board, P. (1999) Biochem. J. 337, 141-151
18. Doublie, S. (1997) Methods Enzymol. 276, 523-530
19. Tong, Z., Board, P. G., and Anders, M. W. (1998) Chem. Res. Toxicol. 11, 1332-1338
20. Axelsson, K., Eriksson, S., and Mannervik, B. (1978) Biochemistry 17, 2978-2984
21. Wells, W. W., Xu, D. P., and Washburn, M. P. (1995) Methods Enzymol. 252, 30-38
22. Board, P. G. (1998) Biochem. J. 330, 827-831
23. Otwinowski, Z., and Minor, W. (1997) Methods Enzymol. 276, 307-326
24. Bailey, S. (1994) Acta Crystallogr. Sec. D 50, 760-763
25. Tong, L., and Rossmann, M. G. (1993) J. Appl. Crystallogr. 26, 15-21
26. De La Fontelle, E., and Bricogne, G. (1997) Methods Enzymol. 276, 472-494
27. Abrahams, J. P., and Leslie, A. G. W. (1996) Acta Crystallogr. Sec. D 52, 30-42
28. Jones, T. A., Zou, J. Y., Cowan, S. W., and Kjeldgaard, M. (1991) Acta Crystallogr. Sec. A 47, 110-119
29. Brugner, A. T. (1996) X-PLOR, Version 3.1 , Yale University Press, New Haven, Connecticut
30. Read, R. J. (1986) Acta Crystallogr. Sec. A 42, 140-149
31. Mannervik, B., Awasthi, Y. C., Board, P. G., Hayes, J. D., Di Ilio, C., Ketterer, B., Listowsky, I., Morgenstern, R., Muramatsu, M., Pearson, W. R., Pickett, C. B., Sato, K., Widersten, M., and Wolf, C. R. (1992) Biochem. J. 282, 305-306
32. Ishikawa, T., Casini, A. F., and Nishikimi, M. (1998) J. Biol. Chem. 273, 28708-28712
33. Paolicchi, A., Pezzini, A., Saviozzi, M., Piaggi, S., Andreuccetti, M., Chieli, E., Malvaldi, G., and Casini, A. F. (1996) Arch. Biochem. Biophys. 333, 489-495
34. Sinning, I., Kleywegt, G. J., Cowan, S. W., Reinemer, P., Dirr, H. W., Huber, R., Gilliland, G. L., Armstrong, R. N., Ji, X., Board, P. G., Olin, B., Mannervik, B., and Jones, T. A. (1993) J. Mol. Biol. 232, 192-212
35. Dal Monte, M., Cecconi, I., Buono, F., Vilardo, P. G., Del Corso, A., and Mura, U. (1998) Biochem. J. 334, 57-62
36. Rossjohn, J., Polekhina, G., Feil, S. C., Allocati, N., Masulli, M., De Illio, C., and Parker, M. W. (1998) Structure (Lond.) 6, 721-734
37. Patskovsky, Y. V., Patskovska, L. N., and Listowsky, I. (2000) J. Biol. Chem. 275, 3296-3304
38. Kortemme, T., and Creighton, T. E. (1995) J. Mol. Biol. 253, 799-812
39. Reinemer, P., Prade, L., Hof, P., Neuefeind, T., Huber, R., Zettl, R., Palme, K., Schell, J., Koelln, I., Bartunik, H. D., and Bieseler, B. (1996) J. Mol. Biol. 255, 289-309
40. Wilce, M. C., Board, P. G., Feil, S. C., and Parker, M. W. (1995) EMBO J. 14, 2133-2143
41. Retief, J. D., Lynch, K. R., and Pearson, W. R. (1999) Genome Res. 9, 373-382
42. Armstrong, R. N. (1997) Chem. Res. Toxicol. 10, 2-18
43. Flanagan, J. U., Rossjohn, J., Parker, M. W., Board, P. G., and Chelvanayagam, G. (1999) Protein Sci. 8, 2205-2212
44. Tan, K. L., Chelvanayagam, G., Parker, M. W., and Board, P. G. (1996) Biochem. J. 319, 315-321
45. Tong, Z., Board, P. G., and Anders, M. W. (1998) Biochem. J. 331, 371-374
46. Seres, T., Ravichandran, V., Moriguchi, T., Rokutan, K., Thomas, J. A., and Johnston, R. B., Jr. (1996) J. Immunol. 156, 1973-1980
47. Hanson, S. R., Chen, A. A., Smith, J. B., and Lou, M. F. (1999) J. Biol. Chem. 274, 4735-4742
48. Ravichandran, V., Seres, T., Moriguchi, T., Thomas, J. A., and Johnston, R. B., Jr. (1994) J. Biol. Chem. 269, 25010-25015
49. Jahngen-Hodge, J., Obin, M. S., Gong, X., Shang, F., Nowell, T. R., Jr., Gong, J., Abasi, H., Blumberg, J., and Taylor, A. (1997) J. Biol. Chem. 272, 28218-28226
50. Kodym, R., Calkins, P., and Story, M. (1999) J. Biol. Chem. 274, 5131-5137
51. Kabsch, W., and Sander, C. (1983) Biopolymers 22, 2577-2637
52. Carson, M. (1997) Methods Enzymol. 277, 493-505
53. Cameron, A. D., Sinning, I., L'Hermite, G., Olin, B., Board, P. G., Mannervik, B., and Jones, T. A. (1995) Structure (Lond.) 3, 717-727
54. Rossjohn, J., McKinstry, W. J., Oakley, A. J., Verger, D., Flanagan, J., Chelvanayagam, G., Tan, K. L., Board, P. G., and Parker, M. W. (1998) Structure (Lond.) 6, 309-322
55. Raghunathan, S., Chandross, R. J., Kretsinger, R. H., Allison, T. J., Penington, C. J., and Rule, G. S. (1994) J. Mol. Biol. 238, 815-832
56. Garcia-Saez, I., Parraga, A., Phillips, M. F., Mantle, T. J., and Coll, M. (1994) J. Mol. Biol. 237, 298-314
57. Ji, X., von Rosenvinge, E. C., Johnson, W. W., Tomarev, S. I., Piatigorsky, J., Armstrong, R. N., and Gilliland, G. L. (1995) Biochem. 34, 5317-5328
58. Kraulis, P. J. (1991) J. Appl. Crystallogr. 24, 945-949
59. Merritt, E. A., and Bacon, D. J. (1997) Methods Enzymol. 277, 505-524
60. Nicholls, A., Sharp, K. A., and Honig, B. (1991) Proteins: Structure, Function, Genetics 11, 281-296
61. Wallace, A. C., Laskowski, R. A., and Thornton, J. M. (1995) Protein Eng. 8, 127-134


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg